Patients who receive more cells get significant benefits. That’s a key lesson emerging from a clinical trial that was reported at the American Heart Association meeting in Chicago. In this … Continue Reading Dosage determined in landmark human study of stem cell therapy for heart attack.
The US FDA has cleared the NephroCheck test, a first-of-a-kind laboratory test to help determine if critically ill hospitalized patients are at risk of developing moderate to severe acute kidney … Continue Reading The FDA clears first-ever test to assess risk of developing acute kidney injury.
Review of ADHD drug approvals highlights gaps between approval process, long-term safety assessment.
Review of ADHD drug approvals highlights gaps between approval process, long-term safety assessment. Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events. The study highlights gaps in how the long-term safety of drugs intended for chronic use in children is assessed as part of the FDA approval process.
Thoughts health innovators?
“When you discover something novel the medical imperative is to come up with a good use for it” ….. Paul Janssen I was approached to report on a Reuters webinar … Continue Reading Healthinnovations on Thomson Reuters: New Techniques in Drug Discovery.
Following trends in my sector always enables me to smell a new wave movement the size of a Tsunami coming. The first inkling I got were the release of statistics … Continue Reading Will Obesity Become The New Cancer